Cargando…
Prediction of therapeutic value of new drugs approved by health Canada from 2011−2020: A cross-sectional study
OBJECTIVES: To examine whether a combination of three characteristics of new drugs – review type, outcome of premarket trials (surrogate or clinical) and first-in-class is associated with significant therapeutic value. DESIGN: Cross-sectional analysis of new drugs approved by Health Canada from Janu...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
SAGE Publications
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10225954/ https://www.ncbi.nlm.nih.gov/pubmed/37255526 http://dx.doi.org/10.1177/20542704231166620 |